In the SELECT cardiovascular outcomes trial, the magnitude of weight loss did not correlate with the degree of benefit in reducing heart attack, stroke, and cardiovascular death, indicating that GLP-1 cardiovascular benefits are separable from weight loss.
factualpending
Speaker
Unidentified Speaker — GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery [5nGTUaqKmcY]Evidence Quote
“in the select cardiovascular outcomes trial studying people with obesity the extent of weight loss did not correlate with the effects of the drug to reduce heart attack stroke and cardiovascular death”
Created: 8/11/2026, 7:45:10 AM
Your notes
Loading notes...